Mandy Robertson, MD, joins the community oncology practice.

OLYMPIA, Wash., January 29, 2024 – Vista Oncology, a partner practice of American Oncology Network (AON) (Nasdaq: AONC), is pleased to welcome new physician Mandy Robertson, MD, to its care team and is now accepting patients at the Olympia clinic location.

Dr. Robertson is Board-certified in internal medicine, medical oncology and hematology. She received her medical degree from the University of Florida in Gainesville, Florida. She then completed her internal medicine residency at Virginia Medical Center in Seattle, Washington, and a hematology-oncology fellowship at the University of Florida College of Medicine.

“It is a pleasure to be joining the team at Vista Oncology,” said Dr. Robertson. “I have been impressed by the physicians and the level of care provided at the practice. My decision to join the team stems from the shared values of integrity and compassion. My goal is to contribute to the continued success of Vista Oncology, and I am eager to collaborate with my fellow physicians to improve the health of our community and provide care to our patients who have trusted us with their care.”

Dr. Robertson will join Vista Oncology’s other Board-certified physicians: Ahmad Ali Fora, MD; Min S. Kang, MD, MS; Linli Xuan, MD; and Joseph Z. Ye, MD.

“On behalf of the entire team at Vista Oncology, it is my honor to welcome Dr. Robertson to our practice,” said Joseph Z. Ye, MD, medical oncologist at Vista Oncology. “Her passion for patient care and commitment to excellence in cancer care align seamlessly with our values. This is an exciting moment for our practice because we are able to expand our physician team, allowing us to serve more patients, as well as increase our capabilities to continue providing our comprehensive cancer care and therapies.”

“Congratulations to Vista Oncology on expanding their physician team to include Dr. Robertson,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “She brings a wealth of valuable knowledge and experience to the practice. I look forward to witnessing the positive impact she will have on the health and well-being of our patients in the community.”

For more information about AON, visit www.AONcology.com. For more information about Vista Oncology, visit www.vista-oncology.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 220 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at www.AONcology.com.

About Vista Oncology
We offer the most comprehensive levels of comfort, care, and compassion. Vista utilizes the most advanced treatments and every available resource, from recent molecular studies to industry-sponsored clinical trials in order to ensure patient-tailored cancer survivorship on every step of the journey. Vista’s partners and care teams are leaders in scientific discovery for the prevention, treatment, and curing of cancer. They include UW Medicine, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, and Virginia Mason Medical Center. Our partners and care teams offer cutting-edge care options and nationally recognized research teams. Learn more at www.vista-oncology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

The network’s physicians’ research reports were selected after a thorough peer review process.

FORT MYERS, Fla., December 21, 2023 –  American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing networks of community oncology practices, is pleased to announce its physicians Ruemu E. Birhiray, MD; Ralph V. Boccia, MD, FACP; and Arvind Chaudhry, MD, PhD, were selected to present their research results at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, California, which was held on December 9 through December 12.

Each year, over 5,000 scientific abstracts undergo a meticulous and thorough peer review process, with only a select few earning acceptances for oral and poster presentations at the annual meeting and exposition. The selected abstracts epitomize crucial and innovative research in the field.

The following AON physician investigators presented their research results during poster discussions and presentations at the annual meeting:

• Dr. Ruemu E. Birhiray, Board-certified medical oncologist at Hematology Oncology of Indiana, authored two reports: “Clinical Research in the Community” and “DEI in Clinical Trials: Where Are We Now and Where We Should Strive to be.” Dr. Birhiray also served as moderator of the session “Setting Realistic Goals for DEI in Hematology Trials.”
• Dr. Ralph V. Boccia, Board-certified medical oncologist at The Center for Cancer and Blood Disorders, served as coauthor of several reports: “Brentuximab Vedotin in Frontline Therapy of Hodgkin Lymphoma in Patients with Significant Comorbidities Ineligible for Standard Chemotherapy (SGN35-015 Part E),” “A Phase 1 Trial Evaluating the Addition of Lenalidomide to Relapsed/Refractory Multiple Myeloma Patients Progressing on Ruxolitinib and Methylprednisolone,” “Multiple Myeloma: Prospective Therapeutic Trials: Poster III,” and “Hodgkin Lymphomas and T/NK Cell Lymphomas: Clinical and Epidemiological: Poster III.”
• Dr. Arvind Chaudhry, Board-certified medical oncologist at Summit Cancer Centers, served as coauthor of one report: “Bellwave-010: Phase 3, Open-Label, Randomized Study of Nemtabrutinib Plus Venetoclax Versus Venetoclax Plus Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Following at Least One Prior Therapy.”

“Having the opportunity to share and present your research at the annual meeting is a proud accomplishment,” said Dr. Boccia, who also serves as AON Research Committee Chairman. “As physicians, we are on the front lines of patient care, and our research is an extension of that commitment. This platform highlights the alignment between medical inquiry and improved patient outcomes, emphasizing the imperative for physicians to actively contribute to the continuous advancements of medical knowledge. Let this moment energize us to persist in our pursuit of medical knowledge that contributes meaningfully to the well-being of those we serve.”

“It is with immense pride and honor that I acknowledge the physicians in our network who have been selected to share their research reports with colleagues from across the nation,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Their commitment to research and the betterment of patient care is a testament to the caliber of physicians we have at AON. I am grateful to be a part of a network of physicians who are advancing healthcare through research and are pushing the boundaries of healthcare innovation to improve patient outcomes.”

According to the ASH website, the in-person and virtual annual meeting and exposition brought together medical professionals who specialize in hematology care for four days of immersive learning, networking, and knowledge-sharing opportunities. It featured the latest educational and scientific content in hematology, designed to help attendees learn from the top minds in the field.

For more information about AON, visit www.AONcology.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 220 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

Local Casa Grande community oncology practice announces its new clinic location and additional cancer care services including PET/CT.

CASA GRANDE, Ariz., December 11, 2023 –  Cancer & Blood Specialists of Arizona, a partner practice of American Oncology Network (AON) (Nasdaq: AONC), announced today the relocation of its main clinic to 1281 East Cottonwood Lane in Casa Grande.

The new site is over 14,000 square feet and accommodates 10 private exam rooms and 20 infusion chairs. Additionally, the clinic is equipped with enhanced services such as diagnostic PET/CT imaging and state-of-the-art TruBeam radiation treatments.

“We are very excited about our new clinic and the services we can now offer our patients,” said Carlos E. Arce-Lara, MD, medical oncologist and hematologist at CBSA. “As a community oncologist, it is very important to have the space as well as tools to treat our patients with the newest treatments and diagnostic equipment as close to home as possible. Patients in Casa Grande will value this new treatment site greatly.”

“To better serve our patients, it is important that our clinics are able to deliver total comprehensive care in a space outfitted with the latest treatment options and equipment,” said Stephen “Fred” Divers, MD, chief medical officer at AON. “The new clinic provides ample space for our providers to deliver the same high-quality patient care they are known for while offering patients additional services in the form of PET/CT scans and radiation treatments. Congratulations to the clinic for securing this expansion and new services.”

Cancer & Blood Specialists of Arizona joined AON in early 2021. As part of the partnership, the clinic and providers have access to AON’s wide variety of services and support that allow them to practice with a patient-first mindset. Such services include access to AON’s in-house pathology and laboratory, specialty pharmacy for oral oncolytic medications and integrated patient care management.

“I am very proud to serve this community and be able to advance the field of oncology,” said Dr. Arce-Lara. “Thank you to American Oncology Network for this important investment and for being a partner in the growth of Casa Grande and Pinal County as a whole.”

For more information about AON, visit www.aoncology.com. For more information about CBSA, visit www.cancerbloodspecialistsaz.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 220 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

About Cancer & Blood Specialists of Arizona
We are experienced physicians, nurse practitioners, nurses and clinical support staff who work collaboratively with our administrative support care team to provide compassionate, patient-centered care. With over 40 years of collective experience in the Casa Grande and Flagstaff areas, our physicians have a history of delivering the highest quality oncologic and hematologic care treatment that is based on cutting-edge research and experience. We work together as a team providing care with empathy, respect, and consideration of what is best for the whole person throughout your cancer fight. As each cancer journey is unique, we deliver the most advanced and innovative treatments tailored to every patient for the best possible outcome and experience. Learn more at www.cancerbloodspecialistsaz.com.  

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

Dr. Shah is a Board-certified medical oncologist and hematologist and sees patients at the Columbus clinic.

COLUMBUS, Ohio, November 6, 2023 –  Zangmeister Cancer Center and American Oncology Network (AON) (NASDAQ: AONC) are pleased to welcome Hiral A. Shah, MD, to the clinic. Dr. Shah is now accepting patients at the Columbus clinic.

Dr. Shah is a Board-certified physician specializing in medical oncology and hematology. She received her medical degree from Northeastern Ohio College of Medicine in Rootstown, Ohio, and has over 10 years of experience treating various cancer types. “It is an honor to be joining the physicians at Zangmeister Cancer Center,” said Shah. “Zangmeister has been a trusted cancer clinic in the community since its founding in 2007. The physicians carry high credibility, and I am excited to join them and their mission to advance cancer services and treatments as well as provide compassionate patient care.”

Zangmeister Cancer Center is equipped to deliver state-of-the-art and comprehensive cancer treatment in a compassionate and comforting environment. There are three locations including the main clinic in Columbus, a second clinic in Grove City and a third clinic in Westerville.

“Dr. Shah is an exceptional physician and will be an asset to our clinic,” said Jeanna L. Knoble, MD, medical oncologist and hematologist at Zangmeister Cancer Center. “We are continuously looking for opportunities to improve our patient care and services, and one way we can keep this promise is by inviting experienced physicians to join us in our efforts to elevate patient care and effectively serve our cancer patients.”

As a partner practice of AON, one of the fastest-growing networks of community oncology practices in the United States, the practice has access to a variety of services and resources that support the clinic’s patient care initiatives.

“Zangmeister Cancer Center was one of the first practices to join the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “We have witnessed the positive impact the physicians and staff have made in the communities they serve. Dr. Shah is an excellent addition to the care team. Congratulations to the practice on its expansion of the physician team.”

For more information about AON, visit www.aoncology.com. For more information about Zangmeister Cancer Center, visit www.zangcenter.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents more than 220 providers practicing across 20 states. The executive management team of AON encompasses more than four decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com.

About Zangmeister Cancer Center
Designed for easy access and patient comfort, the center offers all of the services patients need as part of their cancer care, including diagnostic imaging and chemotherapy treatment, laboratory services, genetic consultation, a specialty pharmacy, social support services and access to cancer clinical trials. Our highly skilled and compassionate physicians use the latest advancements in the diagnosis, treatment and prevention of cancer and blood disorders. Learn more at www.zangcenter.com.  

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network, LLC
Caroline.Hewitt@AONcology.com

Members of AON’s leadership team will speak and moderate several panel sessions at the Summit.

FORT MYERS, Fla., October 18, 2023 – American Oncology Network (AON) (Nasdaq: AONC) is pleased to announce that Stephen “Fred” Divers, MD, chief medical officer; James Gilmore, PharmD, chief pharmacy and clinical services officer; and Alti Rahman, MHA, MBA, CSSBB, chief strategy and innovation officer; and Susan Sabo-Wagner, MSN, RN, OCN, vice president of clinical innovation, have been invited to speak at the Association for Value-Based Cancer Care (AVBCC) 2023 Summit. The in-person event is scheduled for October 18 through October 20 in New York.

Divers, Gilmore, Rahman and Sabo-Wagner, who are members of AON’s leadership team, serve as Summit faculty and will be speaking and moderating specific sessions:

• Divers will participate on the panel for the following session: “Clinician Leadership Role in Transforming Cancer Care.”
• Gilmore will participate on the panel for the following session: “Value-Based Agreements in Oncology: What Cancer Care Practices are Doing in the Marketplace Today.”
• Rahman will participate on the panel for the following sessions: “Challenges in Transitioning to Value-Based Care,” “Transforming the Oncology Practice Clinically and Financially,” “The Essential to Achieving Success in Value-Based Care: Medically Integrated Pharmacies & Dispensaries,” and “How Do I Handle Bundle Payments.” Rahman will also moderate the following panel sessions: “Beyond EOM: How does Health Equity Fit in Multi-Stakeholder Value-Based Care Partnership” and “Artificial Intelligence and the Impact on Care Delivery Outcomes.” 
• Sabo-Wagner will participate on the panel for the following session: “Beyond EOM: How does Health Equity Fit in Multi-Stakeholder Value-Based Care Partnership.”

“Cancer is constantly evolving, and it requires us, as healthcare leaders and patient advocates, to follow suit and continuously elevate our learning so that we can improve patient outcomes,” said Divers, who also serves as a board member of Community Oncology Alliance. “The cancer fight is everyone’s responsibility and so much can be learned by looking to our partners throughout the industry and taking note of best practices. I am excited and honored to be a part of the panel discussion and to see my fellow AON leaders speaking in sessions so that we can explore best cancer practices in today’s environment together.”

“Value-based care is a main force that can close the cancer care gap and create healthcare equity,” said Rahman, who also serves as co-chair of AVBCC and a board member of Community Oncology Alliance. “I am passionate about these topics and sharing my knowledge in hopes to educate and inspire others to learn more about value-based care and more importantly, look for ways to increase access to care so that everyone can receive the right care at the right time.”

According to the AVBCC website, the Summit brings together over 300 experts across the oncology landscape including practitioners, pharmacists, payers, policymakers and other key stakeholders. Filled with various educational sessions, attendees will gain insightful and relevant information that can be implemented in clinics and institutions.

“We are honored to have representatives from AON speaking at this prestigious event,” said Todd Schonherz, AON’s chief executive officer. “To us as an organization, it is important that we consistently work toward being at the forefront of cancer care. We do this by sharing our expertise in the field with others so that cancer care is elevated and progresses alongside the advancements in medicine and technology.”

In addition to speaking at the Summit, Rahman and Sabo-Wagner have been invited to speak at the Community Oncology Alliance (COA) Payer Exchange Summit on Oncology Payment Reform event in late October and the Patient-Centered Oncology Care® conference in early November.

For more information about AON, visit www.aoncology.com. To learn more about the AVBCC’s Summit, visit www.valuebasedcancer.com/avbcc/2023-summit.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 96 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than four decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com